Boston, Mass. From the Division of Plastic and Reconstructive Surgery, Massachusetts General Hospital, Harvard Medical School; the Center for Regenerative Medicine, Harvard Stem Cell Institute; the Division of Infectious Diseases, Children's Hospital Boston, Harvard Medical School; and the Department of Microbiology and Molecular Genetics, Harvard Medical School.
Plast Reconstr Surg. 2011 Nov;128(5):1061-1068. doi: 10.1097/PRS.0b013e31822b65af.
There has been increasing use of synthetic and acellular dermal matrix materials in surgery, ranging from breast reconstruction to hernia repairs. There is a paucity of data on how acellular dermal matrix compares with other surgical materials as a substrate for bacterial adhesion, the first step in formation biofilm, which occurs in prosthetic wound infections. The authors have designed a high-throughput assay to evaluate Staphylococcus aureus adherence on various synthetic and biologically derived materials.
Clinical isolates of S. aureus (strains SC-1 and UAMS-1) were cultured with different materials, and bacterial adherence was measured using a resazurin cell vitality assay. Four materials that are commonly used in surgery were evaluated: Prolene mesh, Vicryl mesh, and two different acellular dermal matrix preparations (AlloDerm and FlexHD). The authors were able to develop a high-throughput and reliable assay for quantifying bacterial adhesion on synthetic and biologically derived materials.
The resazurin vitality assay can be reliably used to quantify bacterial adherence to acellular dermal matrix material and synthetic material. S. aureus strains SC-1 and UAMS-1 both adhered better to acellular dermal matrix materials (AlloDerm versus FlexHD) than to the synthetic material Prolene. S. aureus also adhered better to Vicryl than to Prolene. Strain UAMS-1 adhered better to Vicryl and acellular dermal matrix materials than did strain SC-1.
The results show that S. aureus adheres more readily to acellular dermal matrix material than to synthetic material. The resazurin assay provides a standard method for evaluating surgical materials with regard to bacterial adherence and potential propensity for biofilm development.
在从乳房重建到疝修补等手术中,越来越多地使用合成和去细胞真皮基质材料。关于去细胞真皮基质作为细菌黏附的基质(生物膜形成的第一步,发生在假体伤口感染中)与其他外科材料相比的情况,数据很少。作者设计了一种高通量测定法来评估各种合成和生物衍生材料上金黄色葡萄球菌的黏附。
用不同的材料培养金黄色葡萄球菌(SC-1 和 UAMS-1 株)的临床分离株,并用 Resazurin 细胞活力测定法测量细菌黏附。评估了四种在外科中常用的材料:Prolene 网、Vicryl 网和两种不同的去细胞真皮基质制剂(AlloDerm 和 FlexHD)。作者能够开发出一种高通量且可靠的测定法来定量测定合成和生物衍生材料上的细菌黏附。
Resazurin 活力测定法可可靠地用于定量测定金黄色葡萄球菌对去细胞真皮基质材料和合成材料的黏附。金黄色葡萄球菌株 SC-1 和 UAMS-1 均比合成材料 Prolene 更易黏附于去细胞真皮基质材料(AlloDerm 对 FlexHD)。金黄色葡萄球菌也比 Prolene 更易黏附于 Vicryl。与 SC-1 相比,UAMS-1 株对 Vicryl 和去细胞真皮基质材料的黏附更好。
结果表明,金黄色葡萄球菌更容易黏附于去细胞真皮基质材料而不是合成材料。Resazurin 测定法为评估外科材料的细菌黏附及其潜在生物膜形成倾向提供了一种标准方法。